drugset / Trial / NCT00249769
Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine
Phase 3
Completed
600 enrolled
PATH
Mahidol University · collabQuintiles, Inc. · collabResearch Institute for Tropical Medicine, Manila, Philippines · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
This study will determine whether it is safe and effective to administer Japanese encephalitis (JE) live attenuated SA 14-14-2 vaccine at the same time as measles vaccine. If it is found to be safe, it will pave the way for use in routine vaccination programs. The hypothesis is that children who receive JE live attenuated SA 14-14-2 vaccine and measles vaccine at the same time are protected against these diseases at the same level as those who receive the vaccines at different intervals.
Timeline
- Start
- 2005-11-21
- Primary completion
- 2006-05-30
- Completion
- 2006-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Live Japanese encephalitis vaccine SA 14-14-2 | Vaccine | 0.5 ml | Subcutaneous |
| Subject | Measles vaccine | Vaccine | 0.5 ml | Subcutaneous |